We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+3.29%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.24B
AUM Growth
-$83.1M
(-6.3%)
Cap. Flow
-$36.7M
Cap. Flow
% of AUM
-2.97%
Top 10 Holdings %
Top 10 Hldgs %
21.29%
Holding
139
New
26
Increased
28
Reduced
58
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$22.9M |
| 2 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
+$21.8M |
| 3 |
CNVY
Convey Health Solutions Holdings, Inc.
CNVY
|
+$20.3M |
| 4 |
Aveanna Healthcare
AVAH
|
+$19.7M |
| 5 |
Insmed
INSM
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPD
PPD, Inc. Common Stock
PPD
|
+$32.3M |
| 2 |
Atea Pharmaceuticals
AVIR
|
+$24M |
| 3 |
Novavax
NVAX
|
+$18.8M |
| 4 |
Arvinas
ARVN
|
+$13M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
+$12.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 94.02% |
| 2 | Industrials | 4.68% |
| 3 | Financials | 0.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOLX
76
DELISTED
Hologic
HOLX
| $6.42M | 0.52% |
96,300
-66,500
| -41% | -$4.45M |
|
77
BioMarin Pharmaceuticals
BMRN
$11.7B
| $6.07M | 0.49% |
72,722
-14,750
| -17% | -$1.17M |
|
78
Icon
ICLR
$12.8B
| $5.94M | 0.48% |
+28,750
| New | +$6.2M |
|
79
Merck
MRK
$321B
| $5.85M | 0.47% |
+75,250
| New | +$5.6M |
|
80
Tenet Healthcare
THC
$21.8B
| $5.69M | 0.46% |
+85,000
| New | +$5.27M |
|
81
Cigna
CI
$76.1B
| $5.67M | 0.46% |
23,897
-2,400
| -9% | -$599K |
|
82
Natera
NTRA
$38.6B
| $5.66M | 0.46% |
49,850
-79,000
| -61% | -$8.08M |
|
|
SWAV
83
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $5.31M | 0.43% |
+28,000
| New | +$4.58M |
|
84
Thermo Fisher Scientific
TMO
$214B
| $5.25M | 0.42% |
10,400
| – | – |
|
|
FRLN
85
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $5.22M | 0.42% |
42,714
-919
| -2% | -$143K |
|
86
Denali Therapeutics
DNLI
$3.86B
| $5.1M | 0.41% |
65,000
+61,000
| +1,525% | +$3.77M |
|
87
Boston Scientific
BSX
$68.4B
| $4.96M | 0.4% |
115,976
+13,250
| +13% | +$557K |
|
|
ONCR
88
DELISTED
Oncorus, Inc.
ONCR
| $4.62M | 0.37% |
335,000
| – | – |
|
89
Danaher
DHR
$138B
| $4.5M | 0.36% |
18,922
| – | – |
|
|
VIRX
90
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $4.49M | 0.36% |
395,739
-251,817
| -39% | -$2.53M |
|
|
FNCH
91
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
| $4.23M | 0.34% |
10,013
-2,987
| -23% | -$1.29M |
|
92
Bolt Biotherapeutics
BOLT
$7.47M
| $3.96M | 0.32% |
12,809
-3,192
| -20% | -$1.3M |
|
|
BLU
93
DELISTED
BELLUS Health Inc.
BLU
| $3.9M | 0.32% |
1,252,940
-22,000
| -2% | -$84K |
|
94
Alpha Teknova
TKNO
$271M
| $3.77M | 0.31% |
+159,060
| New | +$4.03M |
|
95
Stryker
SYK
$133B
| $3.56M | 0.29% |
13,700
| – | – |
|
|
CMPI
96
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| $3.23M | 0.26% |
541,766
| – | – |
|
97
Amgen
AMGN
$209B
| $3.21M | 0.26% |
13,153
-8,150
| -38% | -$2M |
|
98
Tandem Diabetes Care
TNDM
$1.3B
| $3.13M | 0.25% |
32,100
-3,000
| -9% | -$268K |
|
99
Moderna
MRNA
$23B
| $2.97M | 0.24% |
12,650
-3,200
| -20% | -$572K |
|
100
Monte Rosa Therapeutics
GLUE
$1.92B
| $2.94M | 0.24% |
+129,633
| New | +$2.64M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Sectoral Asset Management held 139 positions worth $1.24B, down 6.3% from $1.32B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Sectoral Asset Management's Q2 2021 filing shows 26 new, 28 increased, 58 reduced and 12 closed positions. Its largest new stake was Syneos Health, Inc. Class A Common Stock: 271,206 shares worth $24.3M. The largest sale was PPD, Inc. Common Stock, an estimated $32.3M.
By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 94% a quarter earlier, followed by Industrials and Financials.
- Sectoral Asset Management's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 271,206 shares worth $24.3M.
- Sectoral Asset Management added most to Insmed in Q2 2021, an estimated $16.1M increase.
- Sectoral Asset Management's biggest Q2 2021 reduction was Atea Pharmaceuticals, cutting an estimated $24M.
- Sectoral Asset Management fully exited PPD, Inc. Common Stock in Q2 2021, selling an estimated $32.3M.
- Sectoral Asset Management's ten largest holdings make up 21% of its $1.24B portfolio in Q2 2021.
- Sectoral Asset Management opened 26 new positions and closed 12 in Q2 2021.
- Sectoral Asset Management's portfolio value fell 6.3% quarter-over-quarter to $1.24B.
Based on Sectoral Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.